Cargando…
Prescription database analyses indicates that the asthma medicine montelukast might protect against dementia: a hypothesis to be verified
BACKGROUND: It has recently been shown that the leukotriene receptor antagonist montelukast rejuvenates aged brains in rats. The question is whether this commonly used, systemic, anti-asthmatic medicine has a similar effect in humans? RESULTS: We approached this issue by doing statistical analyses b...
Autores principales: | Grinde, Bjørn, Engdahl, Bo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5579921/ https://www.ncbi.nlm.nih.gov/pubmed/28874912 http://dx.doi.org/10.1186/s12979-017-0102-7 |
Ejemplares similares
-
A possible effect of montelukast on neurological aging examined by the use of register data
por: Grinde, Bjørn, et al.
Publicado: (2020) -
Montelukast: its role in the treatment of childhood asthma
por: Harmanci, Koray
Publicado: (2007) -
Asthma phenotypes: the intriguing selective intervention with Montelukast
por: Marcello, Cottini, et al.
Publicado: (2016) -
Role of Montelukast in Asthma and Allergic rhinitis patients
por: Zuberi, Faisal Faiyaz, et al.
Publicado: (2020) -
Clinical effectiveness and safety of montelukast in asthma. What are the conclusions from clinical trials and meta-analyses?
por: Hon, Kam Lun Ellis, et al.
Publicado: (2014)